ResearchMoz

Asthma Global Clinical Trials Review, H1, 2012

Publisher Name » GlobalData
Published Date » 2012-06-30
No. Of Pages » 163

GlobalData's clinical trial report, Asthma Global Clinical Trials Review, H1, 2012" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Asthma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Asthma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Asthma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Asthma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Asthma 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America 17
Clinical Trials by BRIC Nations 18
Clinical Trials by G7 Nations 19
Clinical Trials in G7 Nations by Trial Status 20
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Asthma 26
Subjects Recruited Over a Period of Time 37
Prominent Sponsors 38
Top Companies Participating in Asthma Therapeutics Clinical Trials 40
Prominent Drug Comparison 42
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
GlaxoSmithKline plc 59
Clinical Trial Overview of GlaxoSmithKline plc 59
Merck & Co., Inc. 70
Clinical Trial Overview of Merck & Co., Inc. 70
Chiesi Farmaceutici SpA 77
Clinical Trial Overview of Chiesi Farmaceutici SpA 77
Boehringer Ingelheim GmbH 82
Clinical Trial Overview of Boehringer Ingelheim GmbH 82
Pfizer Inc. 84
Clinical Trial Overview of Pfizer Inc. 84
Genentech, Inc. 86
Clinical Trial Overview of Genentech, Inc. 86
MedImmune, LLC 88
Clinical Trial Overview of MedImmune, LLC 88
ALTANA Pharma AG (Inactive) 90
Clinical Trial Overview of ALTANA Pharma AG (Inactive) 90
Teva Pharmaceutical Industries Limited 92
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 92
Dainippon Sumitomo Pharma Co., Ltd. 94
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 94
Novartis AG 95
Clinical Trial Overview of Novartis AG 95
Amphastar Pharmaceuticals, Inc. 103
Clinical Trial Overview of Amphastar Pharmaceuticals, Inc. 103
SkyePharma PLC 104
Clinical Trial Overview of SkyePharma PLC 104
Boehringer Ingelheim Pharmaceuticals, Inc. 105
Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc. 105
Sanofi 106
Clinical Trial Overview of Sanofi 106
Amgen Inc. 107
Clinical Trial Overview of Amgen Inc. 107
Mundipharma International Limited 108
Clinical Trial Overview of Mundipharma International Limited 108
Johnson & Johnson 109
Clinical Trial Overview of Johnson & Johnson 109
Cipla Ltd. 110
Clinical Trial Overview of Cipla Ltd. 110
Clinical Trial Overview of Top Universities / Institutes / Hospitals 111
Imperial College London 111
Clinical Trial Overview of Imperial College London 111
University of Dundee 112
Clinical Trial Overview of University of Dundee 112
Medical Universtity of Lodz 113
Clinical Trial Overview of Medical Universtity of Lodz 113
University of Wisconsin Madison 114
Clinical Trial Overview of University of Wisconsin Madison 114
Laval University 115
Clinical Trial Overview of Laval University 115
Brigham and Women's Hospital 116
Clinical Trial Overview of Brigham and Women's Hospital 116
Johns Hopkins University 117
Clinical Trial Overview of Johns Hopkins University 117
Johann Wolfgang Goethe University Hospitals 118
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 118
University of Rochester 119
Clinical Trial Overview of University of Rochester 119
University of California, San Francisco 120
Clinical Trial Overview of University of California, San Francisco 120
Weill Cornell Medical College 121
Clinical Trial Overview of Weill Cornell Medical College 121
Kyoto University 122
Clinical Trial Overview of Kyoto University 122
Bispebjerg Hospital 123
Clinical Trial Overview of Bispebjerg Hospital 123
The University of North Carolina 124
Clinical Trial Overview of The University of North Carolina 124
Woolcock Institute of Medical Research 125
Clinical Trial Overview of Woolcock Institute of Medical Research 125
Maastricht University Medical Center 126
Clinical Trial Overview of Maastricht University Medical Center 126
Creighton University 127
Clinical Trial Overview of Creighton University 127
Nemours Children's Clinic 128
Clinical Trial Overview of Nemours Children's Clinic 128
Fraunhofer Institute of Toxicology and Experimental Medicine 129
Clinical Trial Overview of Fraunhofer Institute of Toxicology and Experimental Medicine 129
Academic Medical Centre 130
Clinical Trial Overview of Academic Medical Centre 130
Five Key Clinical Profiles 131

Appendix 160
Abbreviations 160
Definitions 160
Research Methodology 161
Secondary Research 161
About GlobalData 162
Contact Us 162
Disclaimer 162
Source 163

List of Tables


Asthma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Asthma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 11
Asthma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 12
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 13
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 14
Asthma Therapeutics Clinical Trials, North America, Top Countries, 2012* 15
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 16
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 17
Asthma Therapeutics Clinical Trials, BRIC Countries, 2012* 18
Asthma Therapeutics Clinical Trials, G7 Countries, 2012* 19
Asthma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 20
Asthma Therapeutics Clinical Trials, E7 Countries, 2012* 21
Asthma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 22
Asthma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 23
Asthma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 24
Asthma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 25
Asthma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 26
Asthma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 27
Asthma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 30
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 37
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 39
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 41
Asthma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 42
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 43
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 59
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 70
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2012* 77
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 82
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 84
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 86
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012* 88
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by ALTANA Pharma AG (Inactive), 2012* 90
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 92
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2012* 94
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 95
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amphastar Pharmaceuticals, Inc., 2012* 103
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by SkyePharma PLC, 2012* 104
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Pharmaceuticals, Inc., 2012* 105
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 106
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 107
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2012* 108
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 109
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipla Ltd., 2012* 110
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 111
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2012* 112
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Universtity of Lodz, 2012* 113
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 114
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2012* 115
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 116
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 117
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012* 118
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2012* 119
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 120
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 121
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 122
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2012* 123
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2012* 124
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Woolcock Institute of Medical Research, 2012* 125
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012* 126
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2012* 127
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nemours Children's Clinic, 2012* 128
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraunhofer Institute of Toxicology and Experimental Medicine, 2012* 129
Asthma Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 130

List of Figures


Asthma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Asthma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Asthma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 12
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 13
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 14
Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 15
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 16
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 17
Asthma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 18
Asthma Therapeutics Clinical Trials, G7 Countries (%), 2012* 19
Asthma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 20
Asthma Therapeutics Clinical Trials, E7 Countries (%), 2012* 21
Asthma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 22
Asthma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 23
Asthma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 24
Asthma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 25
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 37
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 38
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 40
Asthma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 42
GlobalData Methodology 161

Upcoming Reports:

Cosmeceuticals Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2012 - 2018
By - Transparency Market Research
There has been an increase in the disposable income in many countries across the globe. Also, the desire of each individual to maintain a youthful appearance has risen. This demand has led to the developments of unique products which can neither be classified as cosmetics or pharmaceuticals thus giving rise to the market. The Cosmeceuticals industry does not have a lot of regulations, which has facilitated the entry of new players into the market. The developed countries whose major population comprises of aged individuals are the major markets for Cosmeceuticals globally....
Non Small Cell Lung Cancer Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Globally, the Non-Small-Cell Lung Cancer (NSCLC) drug market will increase from USD 4.3 billion in 2009 to USD 6.9 billion in 2019 and the market is growing with a CAGR of 4.84% during 2009 to 2019. The major markets in these segments are the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The global top five global brands in NSCLC with the largest market share are Avastin, Tarceva, Alimta, Gemzar and Taxotere. For growth in the future there are drugs in the pipeline and in clinical trials at the phase 3 process development in the non small cell lung...
Brazil Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
A biomaterial is any substance, natural or synthetic, that is similar to whole or part of a living system or a biomedical device that treats or replaces any organ, tissue or function of the body, especially, a material appropriate for use as prosthesis. Brazil is considered as one of the most promising economies of the world due to the growing number of middle - income consumers. Many market players of medical tourism consider Brazilian market as an attractive destination due to increasing consumer demand, quality services, stable input cost price and excellent medical facilities....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...